Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer work
Bolt Biotherapeutics strikes a major upsized $230M IPO [...]
Bolt Biotherapeutics strikes a major upsized $230M IPO [...]
Vivo Capital and an Investor Syndicate Completes Sale [...]
Vivo Capital's Portfolio Company, Preventice was Bought [...]
Congratulations to Prof. Frances Arnold, the first American [...]
Vivo Portfolio Company, Aadi Bioscience and EOC Pharma [...]
Vivo Capital Appoints New Managing Partners and PartnersJanuary [...]
VISEN Pharmaceuticals Closes $150 Million Series B Financing [...]
Serán Bioscience Announces Investment by Vivo Capital January [...]
Verona Pharma Raises $200Million in Oversubscribed Private Placement [...]
PatientPop Announces $50M in Series C Funding Aug [...]